Hasanzadeh Akbar, Ebadati Arefeh, Dastanpour Lida, Aref Amir R, Sahandi Zangabad Parham, Kalbasi Alireza, Dai Xiaofeng, Mehta Geeta, Ghasemi Amir, Fatahi Yousef, Joshi Suhasini, Hamblin Michael R, Karimi Mahdi
Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 14535, Iran.
Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran 14535, Iran.
ACS Pharmacol Transl Sci. 2023 Nov 14;6(12):1758-1779. doi: 10.1021/acsptsci.3c00102. eCollection 2023 Dec 8.
Personalized medicine is a new approach toward safer and even cheaper treatments with minimal side effects and toxicity. Planning a therapy based on individual properties causes an effective result in a patient's treatment, especially in a complex disease such as cancer. The benefits of personalized medicine include not only early diagnosis with high accuracy but also a more appropriate and effective therapeutic approach based on the unique clinical, genetic, and epigenetic features and biomarker profiles of a specific patient's disease. In order to achieve personalized cancer therapy, understanding cancer biology plays an important role. One of the crucial applications of personalized medicine that has gained consideration more recently due to its capability in developing disease therapy is related to the field of stem cells. We review various applications of pluripotent, somatic, and cancer stem cells in personalized medicine, including targeted cancer therapy, cancer modeling, diagnostics, and drug screening. CRISPR-Cas gene-editing technology is then discussed as a state-of-the-art biotechnological advance with substantial impacts on medical and therapeutic applications. As part of this section, the role of CRISPR-Cas genome editing in recent cancer studies is reviewed as a further example of personalized medicine application.
个性化医疗是一种新的方法,旨在实现更安全、甚至更便宜的治疗,同时使副作用和毒性降至最低。根据个体特征规划治疗方案能在患者治疗中产生有效结果,尤其是在癌症等复杂疾病的治疗中。个性化医疗的益处不仅包括高精度的早期诊断,还包括基于特定患者疾病独特的临床、遗传和表观遗传特征以及生物标志物谱制定更合适、有效的治疗方法。为了实现个性化癌症治疗,了解癌症生物学起着重要作用。由于其在开发疾病治疗方面的能力,个性化医疗最近受到更多关注的关键应用之一与干细胞领域有关。我们综述了多能干细胞、成体干细胞和癌症干细胞在个性化医疗中的各种应用,包括靶向癌症治疗、癌症建模、诊断和药物筛选。接着讨论了CRISPR-Cas基因编辑技术,它是一项具有重大医学和治疗应用影响的前沿生物技术进展。作为本节的一部分,回顾了CRISPR-Cas基因组编辑在近期癌症研究中的作用,作为个性化医疗应用的进一步示例。